Literature DB >> 2116552

Eicosanoid synthesis in children with cholestatic disease.

J Dupont1, O Amédée-Manesme, D Pepin, J Chambaz.   

Abstract

The possibility of malabsorption of triglycerides contained in the diets of children with cholestasis suggests a deficiency of essential fatty acids and, therefore, probable effects on eicosanoid metabolism. Children with either biliary atresia (BA) or syndromatic paucity of interlobular bile ducts (PILBD) were evaluated as to plasma and platelet total lipid fatty acid composition and synthesis of prostaglandins (PG) E1, PGE2, PGI2, PGF2, and thromboxane (TXB2) by whole blood incubated at 37 degrees C for 10 min. In both diseases linoleate deficiency was present as shown by low 18:2 fatty acids in plasma lipids. The children with BA had lower plasma arachidonate than controls but normal eicosanoid synthesis except for excess PGI2. Those with PILBD had low platelet arachidonate and were severely deficient in TXB2 synthesis (less than 10% of controls). Three children with PILBD were fed a supplement of structured triglyceride (Captex 810) intended to provide as much as 10% of energy as linoleate for 2-3 months. Results for these three cases suggested that insufficient linoleate was absorbed to increase plasma linoleate and differences in eicosanoids could not be attributed to linoleate supplementation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2116552     DOI: 10.1007/bf01799688

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  15 in total

1.  Shattuck lecture--allocating scarce medical resources and the availability of organ transplantation. Some moral presuppositions.

Authors:  H T Engelhardt
Journal:  N Engl J Med       Date:  1984-07-05       Impact factor: 91.245

2.  Liver transplantation for biliary atresia.

Authors:  S Iwatsuki; B W Shaw; T E Starzl
Journal:  World J Surg       Date:  1984-02       Impact factor: 3.352

3.  Hepatic transplantation and biliary atresia: early experience in eight patients.

Authors:  N L Ascher; J S Najarian
Journal:  World J Surg       Date:  1984-02       Impact factor: 3.352

4.  Technique and results of operative management of biliary atresia.

Authors:  M Kasai; H Suzuki; E Ohashi; R Ohi; T Chiba; A Okamoto
Journal:  World J Surg       Date:  1978-09       Impact factor: 3.352

5.  Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development, and cardiac murmur.

Authors:  D Alagille; M Odièvre; M Gautier; J P Dommergues
Journal:  J Pediatr       Date:  1975-01       Impact factor: 4.406

6.  Plasma vitamin E levels in children with cholestasis.

Authors:  F Alvarez; D Cresteil; F Lemonnier; A Lemonnier; D Alagille
Journal:  J Pediatr Gastroenterol Nutr       Date:  1984-06       Impact factor: 2.839

7.  Essential fatty acid deficiency after hepatic portoenterostomy for biliary atresia.

Authors:  G R Gourley; P M Farrell; G B Odell
Journal:  Am J Clin Nutr       Date:  1982-12       Impact factor: 7.045

8.  Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): review of 80 cases.

Authors:  D Alagille; A Estrada; M Hadchouel; M Gautier; M Odièvre; J P Dommergues
Journal:  J Pediatr       Date:  1987-02       Impact factor: 4.406

9.  Possible defect in the bile secretory apparatus in arteriohepatic dysplasia (Alagille's syndrome): a review with observations on the ultrastructure of liver.

Authors:  P Valencia-Mayoral; J Weber; E Cutz; V D Edwards; M J Phillips
Journal:  Hepatology       Date:  1984 Jul-Aug       Impact factor: 17.425

10.  Essential fatty acids interconversion in the human fetal liver.

Authors:  J Chambaz; D Ravel; M C Manier; D Pepin; N Mulliez; G Bereziat
Journal:  Biol Neonate       Date:  1985
View more
  1 in total

1.  Fatty acid content in lymphocytes from children with syndromic paucity of interlobular bile ducts, Alagille syndrome.

Authors:  P Pina; M Couturier; F Lemonnier
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.